{
    "id": "dbpedia_3608_2",
    "rank": 93,
    "data": {
        "url": "https://www.fda.gov/medical-devices/laboratory-developed-tests/laboratory-developed-tests-faqs",
        "read_more_link": "",
        "language": "en",
        "title": "Laboratory Developed Tests: FAQs",
        "top_image": "https://www.fda.gov/themes/custom/preview/img/FDA-Social-Graphic.png",
        "meta_img": "https://www.fda.gov/themes/custom/preview/img/FDA-Social-Graphic.png",
        "images": [
            "https://www.fda.gov/themes/custom/preview/assets/images/US_Flag.png",
            "https://www.fda.gov/themes/custom/preview/assets/images/icon-dot-gov.svg",
            "https://www.fda.gov/themes/custom/preview/assets/images/icon-https.svg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [
            "Center for Devices and Radiological Health"
        ],
        "publish_date": "2024-07-22T11:29:00",
        "summary": "",
        "meta_description": "Learn more about the FDA's oversight of LDTs to ensure accurate and reliable tests.",
        "meta_lang": "en",
        "meta_favicon": "/themes/custom/preview/favicon.ico",
        "meta_site_name": "U.S. Food and Drug Administration",
        "canonical_link": "https://www.fda.gov/medical-devices/laboratory-developed-tests/laboratory-developed-tests-faqs",
        "text": "On these pages you’ll find answers to the most common questions FDA has received through ldtfinalrule@fda.hhs.gov related to laboratory developed tests (LDTs). To ensure we are answering generally applicable questions in a manner that is transparent, we intend to respond to questions submitted to the mailbox, as appropriate, in a public manner, such as in webinars, guidances, this FAQ page, and other resources over the course of the phaseout period. FDA intends to update this FAQ page periodically. If you cannot find the answer you’re looking for, please contact FDA through the mailbox at ldtfinalrule@fda.hhs.gov.\n\nDefinitions and General Oversight\n\nPhaseout Policy and Enforcement Discretion Policies\n\nLabeling\n\nPremarket Review\n\nInvestigational Use\n\nSpecific Test Categories or Technologies\n\nResources and Interactions with FDA"
    }
}